12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

GenVec, Novartis deal

GenVec and Novartis extended by one year through January 2013 a 2010 deal granting the pharma exclusive, worldwide rights to GenVec's preclinical...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >